The effects of alewife (Alosa pseudoharengus) on zooplankton community structure in Depot Pond NH and a comparison of seven New Hampshire lakes

Physical, chemical and biological features of seven New Hampshire lakes were examined in September and October of 1997. Zooplankton communities exhibited evidence of “top-down” control in Milton Three Ponds (Depot, Norteast, and Townhouse Ponds), showing effects of a planktivorous fish, Alosa pseudoharengus: small mean body size, dominance of small grazers such as Bosmina, and absence of large grazers such as Daphnia. Phosphorus concentrations were positively correlated to fluorescence of all water fractions, chlorophyll a and a phytoplankton biotic pollution index (modified from Hillsenhoff, 1978), revealing a level of “bottom-up” control

Inadequate lopinavir concentrations with modified 8-hourly lopinavir/ritonavir 4:1 dosing during rifampicin-based tuberculosis treatment in children living with HIV

BACKGROUND: Lopinavir/ritonavir plasma concentrations are profoundly reduced when co-administered with rifampicin. Super-boosting of lopinavir/ritonavir is limited by nonavailability of single-entity ritonavir, while double-dosing of co-formulated lopinavir/ritonavir given twice-daily produces suboptimal lopinavir concentrations in young children. We evaluated whether increased daily dosing with modified 8-hourly lopinavir/ritonavir 4:1 would maintain therapeutic plasma concentrations of lopinavir in children living with HIV receiving rifampicin-based antituberculosis treatment. METHODS: Children with HIV/tuberculosis coinfection weighing 3.0 to 19.9 kg, on rifampicin-based antituberculosis treatment were commenced or switched to 8-hourly liquid lopinavir/ritonavir 4:1 with increased daily dosing using weight-band dosing approach. A standard twice-daily dosing of lopinavir/ritonavir was resumed 2 weeks after completing antituberculosis treatment. Plasma sampling was conducted during and 4 weeks after completing antituberculosis treatment. RESULTS: Of 20 children enrolled; 15, 1-7 years old, had pharmacokinetics sampling available for analysis. Lopinavir concentrations (median [range]) on 8-hourly lopinavir/ritonavir co-administered with rifampicin (n = 15; area under the curve 0-24 55.32 mg/h/L [0.30-398.7 mg/h/L]; C max 3.04 mg/L [0.03-18.6 mg/L]; C 8hr 0.90 mg/L [0.01-13.7 mg/L]) were lower than on standard dosing without rifampicin (n = 12; area under the curve 24 121.63 mg/h/L [2.56-487.3 mg/h/L]; C max 9.45 mg/L [0.39-26.4 mg/L]; C 12hr 3.03 mg/L [0.01-17.7 mg/L]). During and after rifampicin cotreatment, only 7 of 15 (44.7%) and 8 of 12 (66.7%) children, respectively, achieved targeted pre-dose lopinavir concentrations ≥1mg/L. CONCLUSIONS: Modified 8-hourly dosing of lopinavir/ritonavir failed to achieve adequate lopinavir concentrations with concurrent antituberculosis treatment. The subtherapeutic lopinavir exposures on standard dosing after antituberculosis treatment are of concern and requires further evaluation

Au-NHC@Porous Organic Polymers: Synthetic Control and Its Catalytic Application in Alkyne Hydration Reactions

The synthetic control and functions of porous organic polymers (POPs) with N-heterocyclic carbene gold(I) (Au-NHC@POPs) are described in this article. A series of Au-NHC@POPs with tunable physical properties such as surface area and pore size distribution were first synthesized via Sonogashira chemistry by differing monomer strut lengths and concentration during polymerization; a controllable transition from nonporous to microporous and the coexistence of micro- and mesoporous structures in the framework were realized by varying the monomer concentration. To explain this phenomenon, we put forward a model assumption of a branch-branch cross effect. Additionally, Au-NHC@POPs1 was found to have superior catalytic activity in alkyne hydration reactions, and the catalyst could be used six times with a slight loss of activity